Volume | 6,754 |
|
|||||
News | - | ||||||
Day High | 8.08 | Low High |
|||||
Day Low | 7.75 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
BioStem Technologies Inc (PK) | BSEM | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
8.07 | 7.75 | 8.08 | 8.08 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
49 | 6,754 | US$ 7.9447 | US$ 53,659 | - | 1.20 - 15.50 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
12:28:39 | 50 | US$ 7.76 | USD |
BioStem Technologies Inc (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
71.71M | 13.45M | - | 6.88M | -7.08M | -0.77 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
BioStem Technologies (PK) News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BSEM Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 8.80 | 10.05 | 7.65 | 8.88 | 32,938 | -1.04 | -11.82% |
1 Month | 9.32 | 10.05 | 7.61 | 8.93 | 30,237 | -1.56 | -16.74% |
3 Months | 8.52 | 15.50 | 7.61 | 10.41 | 28,622 | -0.76 | -8.92% |
6 Months | 3.10 | 15.50 | 2.61 | 8.47 | 27,829 | 4.66 | 150.32% |
1 Year | 2.05 | 15.50 | 1.20 | 7.47 | 18,958 | 5.71 | 278.54% |
3 Years | 1.25 | 15.50 | 0.1445 | 6.65 | 9,565 | 6.51 | 520.80% |
5 Years | 1.80 | 15.50 | 0.01 | 5.79 | 6,847 | 5.96 | 331.11% |
BioStem Technologies (PK) Description
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida. |